1 Comment
User's avatar
User's avatar
Comment removed
Dec 10
Comment removed
Andrii Buvailo, PhD's avatar

I would say the entire preclinical/clinical drug discovery market for AI/quantum is peanuts compared to the opportunities in the manufacturing world, a different league in terms of both business and impact parameters.